>
PDL BioPharma Inc logo

PDLI - PDL BioPharma Inc Share Price

$2.47 0.0  0.0%

Last Trade - 30/12/20

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £34.5m
Position in Universe th / 7006
Bullish
Bearish
Unlock PDLI Revenue
Momentum
Relative Strength (%)
1m -4.80%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
581.2 590.4 244.3 320.1 198.1 54.8 23.1 32.6 -37.7%
+13.5 +7.5 -70.2 +12.4 -64.0
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the eight months ended 31 August 2020, PDLBioPharma Inc revenues totaled $15.3M. Net loss beforeextraordinary items totaled to $42.4M. Results are notcomparable due to year end change.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for PDLI
Graphical History

Revenue

PDLI Revenue Unlock PDLI Revenue

Net Income

PDLI Net Income Unlock PDLI Revenue

Normalised EPS

PDLI Normalised EPS Unlock PDLI Revenue

PE Ratio Range

PDLI PE Ratio Range Unlock PDLI Revenue

Dividend Yield Range

PDLI Dividend Yield Range Unlock PDLI Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
PDLI EPS Forecasts Unlock PDLI Revenue
Profile Summary

PDL BioPharma Inc is a United States-based company, which is a portfolio of income producing assets based on alternative financing. These alternative financings fall into one of three categories: royalty monetization, debt structures and hybrids of both. The Company's Investments generally involve assets with intellectual property protection and are at the commercial stage or about to be approved. Counterparties to these transactions in biotechnology, pharmacies, medical technology companies, universities and inventors.

Directors
Last Annual December 31st, 2019
Last Interim August 31st, 2020
Incorporated July 24, 1986
Public Since January 29, 1992
No. of Shareholders: n/a
No. of Employees: 75
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange NASDAQ Global Select Market
Shares in Issue 114,226,566
Free Float (0.0%)
Eligible for
ISAs
SIPPs
PDLI Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for PDLI
Upcoming Events for PDLI
Frequently Asked Questions for PDL BioPharma Inc
What is the PDL BioPharma Inc share price?

As of 30/12/20, shares in PDL BioPharma Inc are trading at $2.47, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the PDL BioPharma Inc share price performed this year?

Shares in PDL BioPharma Inc are currently trading at $2.47 and the price has moved by 0.87% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the PDL BioPharma Inc price has moved by -25.32% over the past year.

What are the analyst and broker recommendations for PDL BioPharma Inc?

Of the analysts with advisory recommendations for PDL BioPharma Inc, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for PDL BioPharma Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will PDL BioPharma Inc next release its financial results?

PDL BioPharma Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-08-31
What is the PDL BioPharma Inc dividend yield?

PDL BioPharma Inc does not currently pay a dividend.

Does PDL BioPharma Inc pay a dividend?

PDL BioPharma Inc does not currently pay a dividend.

When does PDL BioPharma Inc next pay dividends?

PDL BioPharma Inc does not currently pay a dividend.

How do I buy PDL BioPharma Inc shares?

To buy shares in PDL BioPharma Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of PDL BioPharma Inc?

Shares in PDL BioPharma Inc are currently trading at $2.47, giving the company a market capitalisation of £n/a.

Where are PDL BioPharma Inc shares listed? Where are PDL BioPharma Inc shares listed?

Here are the trading details for PDL BioPharma Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: PDLI
What kind of share is PDL BioPharma Inc?

We were not able to load our ranking data for PDL BioPharma Inc

Is there a PDL BioPharma Inc share price forecast 2021?

We were not able to load any forecast data for PDL BioPharma Inc.

How can I tell whether the PDL BioPharma Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like PDL BioPharma Inc. Over the past six months, the relative strength of its shares against the market has been -21.37%. At the current price of $2.47, shares in PDL BioPharma Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the PDL BioPharma Inc PE Ratio?

We were not able to find PE ratio data for PDL BioPharma Inc.

Who are the key directors of PDL BioPharma Inc?

PDL BioPharma Inc's management team is headed by:

John McLaughlin - DRC
Christopher Stone - VPR
Dominique Monnet - PRE
Elizabeth O'Farrell - CHM
Edward Imbrogno - CFO
Who are the major shareholders of PDL BioPharma Inc?

Here are the top five shareholders of PDL BioPharma Inc based on the size of their shareholding:

Silver Point Capital, L.P. Hedge Fund
Percentage owned: 20.5% (23.4m shares)
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund
Percentage owned: 8.16% (9.32m shares)
Park West Asset Management LLC Hedge Fund
Percentage owned: 8.03% (9.17m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 7.6% (8.68m shares)
Renaissance Technologies LLC Hedge Fund
Percentage owned: 6.65% (7.60m shares)
Similar to PDLI
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.